Biogen Pharma

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.43
-0.02 (-4.44%)
BSENSE

May 13

BSE+NSE Vol: 1.17 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.43",
    "chg": -0.02,
    "chgp": "-4.44%",
    "dir": -1,
    "prev_price": "0.45",
    "mcapval": "40.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE703D01023",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "1.17 cr",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.42 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs042-3989693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3989693.png",
        "date": "2026-05-13 15:35:07",
        "description": "A sharp decline has pushed Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.42 on 13 May 2026, marking a significant 61% drop from its peak of Rs 1.08 within the last year. This downturn comes despite some improvement in profitability, highlighting a complex interplay of valuation and market sentiment pressures."
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs043-3985795",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3985795.png",
        "date": "2026-05-11 15:35:04",
        "description": "Despite a broad market rally and sectoral strength, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.43 on 11 May 2026, extending its recent downward trajectory amid persistent selling pressure."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.44 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs044-3981761",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3981761.png",
        "date": "2026-05-08 12:40:03",
        "description": "A sharp decline in Biogen Pharmachem Industries Ltd has pushed the stock to a fresh 52-week low of Rs 0.44 on 8 May 2026, marking a 47.06% drop over the past year and signalling intensified selling pressure despite some recent gains in the broader market indices."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3981509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_mojoScore_3981509.png",
        "date": "2026-05-08 10:10:22",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are current as of 08 May 2026, providing investors with an up-to-date view of the company’s position in the market."
      },
      {
        "title": "When is the next results date for Biogen Pharmachem Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biogen-pharmachem-industries-ltd-3976531",
        "imagepath": "",
        "date": "2026-05-05 23:16:32",
        "description": "The next results date for Biogen Pharmachem Industries Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs046-3976146",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3976146.png",
        "date": "2026-05-05 15:35:03",
        "description": ""
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.46 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs046-3966725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiogenPharmache_priceRelatedfactors_3966725.png",
        "date": "2026-04-28 13:40:04",
        "description": "A sharp decline has pushed Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.46 on 28 Apr 2026, marking a 47.25% drop over the past year and underscoring persistent selling pressure despite pockets of financial improvement."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3963133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BiogenPharmache_mojoScore_3963133.png",
        "date": "2026-04-26 10:10:13",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "What is the bonus history of Biogen Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/what-is-the-bonus-history-of-biogen-pharma-3951694",
        "imagepath": "",
        "date": "2026-04-17 23:00:56",
        "description": "Biogen Pharma has a recent bonus issue announced at a ratio of 1:6, with the ex-date set for May 15, 2026. This means that for every six shares held, shareholders will receive one additional share as a bonus. The record date for this bonus issue is also May 15, 2026. If you have any more questions about Biogen or its financial activities, feel free to ask!..."
      }
    ],
    "total": 90,
    "sid": "200854",
    "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.",
      "datetime": "04-May-2026",
      "details": "Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 14th May 2026 inter alia to consider following businesses: - 1.) Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2026 along with the Reports of the Auditors thereon. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "27-Apr-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association",
      "datetime": "27-Apr-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26",
          "dt": "2026-05-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.

04-May-2026 | Source : BSE

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 14th May 2026 inter alia to consider following businesses: - 1.) Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2026 along with the Reports of the Auditors thereon. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.

Shareholder Meeting / Postal Ballot-Scrutinizers Report

27-Apr-2026 | Source : BSE

PFA

Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

27-Apr-2026 | Source : BSE

PFA

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 May 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Biogen Pharmachem Industries Ltd has announced 1:6 bonus issue, ex-date: 15 May 26

stock-summary
RIGHTS

No Rights history available